Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

The number of CD34+ cells has been described as the best parameter for predicting the quality of engraftment in peripheral blood progenitor cell (PBPC) transplantation in the early post-transplant period. In this study we have determined the optimal number of CD34+cells in order to maintain engraftm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 1999-12, Vol.24 (12), p.1279-1283
Hauptverfasser:	PEREZ-SIMON, J. A, MARTIN, A, ORFAO, A, SAN MIGUEL, J. F, CABALLERO, D, CORRAL, M, NIETO, M. J, GONZALEZ, M, VAZQUEZ, L, LOPEZ-BERGES, C, CANIZO, M. C, MATEOS, M. V
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anti-Bacterial Agents - therapeutic use Antibiotics Antigens, CD34 - blood Antigens, CD34 - pharmacology Autografts Biological and medical sciences Blood Blood transfusion Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction CD34 antigen Clinical significance Engraftment Erythrocyte Transfusion Erythrocytes Fever Follow-Up Studies Graft Survival - drug effects Graft Survival - immunology Hematopoietic Stem Cell Transplantation - methods Hematopoietic stem cells Hemopoiesis Hospitalization Humans Infection - complications Leukocytes (neutrophilic) Medical sciences Multivariate Analysis Patients Peripheral blood Progenitor cells Statistical analysis Stem cell transplantation Stem cells Subgroups Time Factors Transfusion Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Autologous Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!